Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

SEC Filings

SEC Filing Keyword Search (View search tips)
Year Filter 
Groupings Filter (View SEC Groupings descriptions)
View Section 16 Filings (3,4,5)
<< First | Previous | Next | Last >>
Filing DateFormDescriptionFiling GroupDownloads
12/10/014Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
12/10/014Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
12/10/014Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
12/10/014Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
12/10/014Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
12/10/014Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
11/27/01424B3Form of prospectus reflecting facts events constituting substantive change from last formRegistration Statements Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
11/05/0110-QQuarterly report which provides a continuing view of a company's financial positionQuarterly Filings Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
08/13/01424B3Form of prospectus reflecting facts events constituting substantive change from last formRegistration Statements Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
08/10/0110-QQuarterly report which provides a continuing view of a company's financial positionQuarterly Filings Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
<< First | Previous | Next | Last >>

Stock Quote

CRL (common)
Price
$145.12
Change (%)
- 0.69 (0.47%)
Volume
207,845
Exchange
NYSE
Data as of 03/20/19 4:02 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)